U.S. Urology Partners is one of the first providers to offer patients ImmunityBio’s recombinant Bacillus Calmette-Guérin (rBCG) The FDA recently authorized ImmunityBio’s EAP for rBCG to address U.S.

Academic researchers in Massachusetts believe the standard BCG (bacillus Calmette-Guérin) vaccine could have a remarkable second use: a treatment to reverse advanced type 1 diabetes. The cause of ...

Nadofaragene firadenovec intravesical gene therapy continues to show promise in treating BCG-unresponsive NMIBC bladder cancer.

What a difference five years can make. Although the global story of the coronavirus pandemic began in December 2019, it would ...

Manager Alison remembers when they had to hand it over to become a testing site, then a vaccination hub. "It was quite sad really. It was quite upsetting because one, we were all a bit anxious ...

Ruben Amorim has revealed that Manchester United players' 'scars' are too deep in order to improve the situation at the club in the future. The Red Devils endure one of the worst campaigns in ...

Mar. 5, 2025 — A live-attenuated tuberculosis (TB) vaccine candidate in development elicits a much more balanced and effective immune response compared to the existing vaccine used across much ...